Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment

RA McCutcheon, RSE Keefe, PK McGuire - Molecular psychiatry, 2023 - nature.com
Cognitive deficits are a core feature of schizophrenia, account for much of the impaired
functioning associated with the disorder and are not responsive to existing treatments. In this …

Muscarinic acetylcholine receptor agonists as novel treatments for schizophrenia

SM Paul, SE Yohn, M Popiolek… - American Journal of …, 2022 - psychiatryonline.org
Schizophrenia remains a challenging disease to treat effectively with current antipsychotic
medications due to their limited efficacy across the entire spectrum of core symptoms as well …

Cholinergic modulation of the hippocampal region and memory function

J Haam, JL Yakel - Journal of neurochemistry, 2017 - Wiley Online Library
Acetylcholine (AC h) plays an important role in memory function and has been implicated in
aging‐related dementia, in which the impairment of hippocampus‐dependent learning …

Hippocampal GABAergic inhibitory interneurons

KA Pelkey, R Chittajallu, MT Craig… - Physiological …, 2017 - journals.physiology.org
In the hippocampus GABAergic local circuit inhibitory interneurons represent only~ 10–15%
of the total neuronal population; however, their remarkable anatomical and physiological …

Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic

SE Yohn, PJ Weiden, CC Felder, SM Stahl - Trends in Pharmacological …, 2022 - cell.com
Modern interest in muscarinic acetylcholine receptor (mAChR) activators for schizophrenia
began in the 1990s when xanomeline, an M 1/M 4-preferring mAChR agonist developed for …

[HTML][HTML] The cerebellum and the Mirror Neuron System: A matter of inhibition? From neurophysiological evidence to neuromodulatory implications. A narrative review

A Antonioni, EM Raho, S Straudi, E Granieri… - Neuroscience & …, 2024 - Elsevier
Mirror neurons show activity during both the execution (AE) and observation of actions (AO).
The Mirror Neuron System (MNS) could be involved during motor imagery (MI) as well …

Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease

E Spoleti, L La Barbera, E Cauzzi, ML De Paolis… - Molecular …, 2024 - nature.com
Early and progressive dysfunctions of the dopaminergic system from the Ventral Tegmental
Area (VTA) have been described in Alzheimer's Disease (AD). During the long pre …

Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's disease

S Hijazi, TS Heistek, P Scheltens, U Neumann… - Molecular …, 2020 - nature.com
Neuronal network dysfunction is increasingly recognized as an early symptom in
Alzheimer's disease (AD) and may provide new entry points for diagnosis and intervention …

The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia

DL Uliana, JRF Lisboa, FV Gomes, AA Grace - Biochemical pharmacology, 2024 - Elsevier
The intricate balance between excitation and inhibition (E/I) in the brain plays a crucial role
in normative information processing. Dysfunctions in the E/I balance have been implicated in …

Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease

EP Lebois, C Thorn, JR Edgerton, M Popiolek, S ** - Neuropharmacology, 2018 - Elsevier
Muscarinic acetylcholine receptors (mAChRs) are G proteincoupled receptors (GPCRs) that
mediate the metabotropic actions of acetylcholine (ACh). There are five subtypes of mAChR …